{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:10:13Z","timestamp":1789783813689,"version":"4.0.1"},"reference-count":57,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,12,1]]},"abstract":"<jats:p>OBJECTIVE. A human papillomavirus vaccine was licensed in June 2006. The vaccine is quadrivalent, protecting against 2 human papillomavirus strains that cause cervical cancer and 2 that cause genital warts. The objective of this study was to determine physician characteristics, knowledge, and attitudes associated with an intention to recommend human papillomavirus vaccination.<\/jats:p>\n               <jats:p>METHODS. Between August and October 2005, a cross-sectional survey was administered to a national network of 431 pediatricians. The network was developed from a random sample of American Academy of Pediatrics members and was designed to be representative of the organization\u2019s membership with respect to urban\/rural location, practice type, and region. The survey was conducted before human papillomavirus vaccine licensure and therefore focused on a candidate quadrivalent human papillomavirus vaccine and a range of potential vaccination recommendations. The main outcome measure was intention to recommend a quadrivalent human papillomavirus vaccine to young adolescent (10- to 12-year-old) females.<\/jats:p>\n               <jats:p>RESULTS. Survey response rate was 68%. If endorsed by national health organizations, 46% of respondents would recommend vaccination for 10- to 12-year-old females, 77% for 13- to 15-year-old females, and 89% for 16- to 18-year-old females. Corresponding rates for males were 37%, 67%, and 82%, respectively. Whereas 60% of respondents thought that parents would be concerned that human papillomavirus vaccination may encourage risky sexual behaviors, 11% reported that they themselves had this concern. Respondents who believed that other new adolescent immunization recommendations (eg, meningococcal, pertussis) would facilitate human papillomavirus vaccine implementation were more likely to intend to recommend vaccination.<\/jats:p>\n               <jats:p>CONCLUSIONS. Although a national sample of pediatricians expressed a high level of acceptance of human papillomavirus vaccination in older adolescent females, fewer than one half anticipated giving human papillomavirus vaccine to younger female patients. Provider concerns about parental vaccine acceptance will need to be addressed to optimize human papillomavirus vaccination implementation.<\/jats:p>","DOI":"10.1542\/peds.2006-1946","type":"journal-article","created":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T17:33:20Z","timestamp":1164994400000},"page":"2280-2289","source":"Crossref","is-referenced-by-count":146,"title":["A National Survey of Pediatrician Knowledge and Attitudes Regarding Human Papillomavirus Vaccination"],"prefix":"10.1542","volume":"118","author":[{"given":"Matthew F.","family":"Daley","sequence":"first","affiliation":[{"name":"Departments of Pediatrics"},{"name":"Preventive Medicine and Biometrics"},{"name":"Family Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Liddon","sequence":"additional","affiliation":[{"name":"Colorado Health Outcomes Program, University of Colorado at Denver and Health Sciences Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Crane","sequence":"additional","affiliation":[{"name":"Family Medicine"},{"name":"Children\u2019s Outcomes Research Program, Children\u2019s Hospital, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda L.","family":"Beaty","sequence":"additional","affiliation":[{"name":"Preventive Medicine and Biometrics"},{"name":"Family Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Barrow","sequence":"additional","affiliation":[{"name":"Preventive Medicine and Biometrics"},{"name":"Family Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Babbel","sequence":"additional","affiliation":[{"name":"Preventive Medicine and Biometrics"},{"name":"Family Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri E.","family":"Markowitz","sequence":"additional","affiliation":[{"name":"Colorado Health Outcomes Program, University of Colorado at Denver and Health Sciences Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen F.","family":"Dunne","sequence":"additional","affiliation":[{"name":"Colorado Health Outcomes Program, University of Colorado at Denver and Health Sciences Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Stokley","sequence":"additional","affiliation":[{"name":"Division of Sexually Transmitted Diseases Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Miriam","family":"Dickinson","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Berman","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"},{"name":"Family Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Kempe","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"},{"name":"Preventive Medicine and Biometrics"},{"name":"Family Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,12,1]]},"reference":[{"key":"2021120823103059400_R1","doi-asserted-by":"crossref","unstructured":"Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex Transm Dis.\u20081999;26:S2\u2013S7","DOI":"10.1097\/00007435-199904001-00002"},{"key":"2021120823103059400_R2","doi-asserted-by":"crossref","unstructured":"Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health.\u20082004;36:6\u201310","DOI":"10.1363\/3600604"},{"key":"2021120823103059400_R3","doi-asserted-by":"crossref","unstructured":"Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med.\u20081998;338:423\u2013428","DOI":"10.1056\/NEJM199802123380703"},{"key":"2021120823103059400_R4","doi-asserted-by":"crossref","unstructured":"Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol.\u20082003;157:218\u2013226","DOI":"10.1093\/aje\/kwf180"},{"key":"2021120823103059400_R5","doi-asserted-by":"crossref","unstructured":"Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet.\u20082001;357:1831\u20131836","DOI":"10.1016\/S0140-6736(00)04956-4"},{"key":"2021120823103059400_R6","doi-asserted-by":"crossref","unstructured":"Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine.\u20082006;24(suppl 1):S1\u2013S15","DOI":"10.1016\/j.vaccine.2005.09.054"},{"key":"2021120823103059400_R7","doi-asserted-by":"crossref","unstructured":"Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol.\u20081999;189:12\u201319","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F"},{"key":"2021120823103059400_R8","unstructured":"Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975\u20132002. National Cancer Institute. Available at: http:\/\/seer.cancer.gov\/csr\/1975\u20132002. Accessed January 26, 2006"},{"key":"2021120823103059400_R9","doi-asserted-by":"crossref","unstructured":"Insinga RP, Glass AG, Rush BB. The health care costs of cervical human papillomavirus\u2013related disease. Am J Obstet Gynecol.\u20082004;191:114\u2013120","DOI":"10.1016\/j.ajog.2004.01.042"},{"key":"2021120823103059400_R10","doi-asserted-by":"crossref","unstructured":"Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Infect Dis.\u20082006;6:21\u201331","DOI":"10.1016\/S1473-3099(05)70323-6"},{"key":"2021120823103059400_R11","doi-asserted-by":"crossref","unstructured":"Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet.\u20082004;364:1757\u20131765","DOI":"10.1016\/S0140-6736(04)17398-4"},{"key":"2021120823103059400_R12","doi-asserted-by":"crossref","unstructured":"Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet.\u20082006;367:1247\u20131255","DOI":"10.1016\/S0140-6736(06)68439-0"},{"key":"2021120823103059400_R13","unstructured":"Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol.\u20082005;6:271\u2013278"},{"key":"2021120823103059400_R14","doi-asserted-by":"crossref","unstructured":"Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med.\u20082003;348:518\u2013527","DOI":"10.1056\/NEJMoa021641"},{"key":"2021120823103059400_R15","doi-asserted-by":"crossref","unstructured":"Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev.\u20081988;10:122\u2013163","DOI":"10.1093\/oxfordjournals.epirev.a036020"},{"key":"2021120823103059400_R16","doi-asserted-by":"crossref","unstructured":"Skjeldestad FE. Prophylactic quadrivalent human papillomavirus (HPV) (types 6, 11, 16, 18) L1 virus-like particle (VLP) vaccine (Gardasil\u2122) reduces cervical intraepithelial neoplasia (CIN) 2\/3 risk. 43rd Annual Meeting of the Infectious Disease Society of America, San Francisco, CA, October 6\u20139, 2005 [Abstract LB-8a]. Available at: www.idsociety.org\/Template.cfm?Section=Home&CONTENTID=14108&TEMPLATE=\/ContentManagement\/ContentDisplay.cfm. Accessed February 6, 2006","DOI":"10.1016\/S1359-6349(05)82013-0"},{"key":"2021120823103059400_R17","unstructured":"US Food and Drug Administration. FDA licenses new vaccine for prevention of cervical cancer and other diseases in females caused by human papillomavirus. Available at: www.fda.gov\/bbs\/topics\/NEWS\/2006\/NEW01385.html. Accessed June 8, 2006"},{"key":"2021120823103059400_R18","unstructured":"Centers for Disease Control and Prevention. Press Release: CDC\u2019s Advisory Committee recommends human papillomavirus virus vaccination. Available at: www.cdc.gov\/od\/oc\/media\/pressrel\/r060629.htm. Accessed July 5, 2006"},{"key":"2021120823103059400_R19","doi-asserted-by":"crossref","unstructured":"Daley MF, Crane LA, Beaty BL, et al. Provider adoption of pneumococcal conjugate vaccine and the impact of vaccine shortages. Ambul Pediatr.\u20082005;5:157\u2013164","DOI":"10.1367\/A04-142R.1"},{"key":"2021120823103059400_R20","doi-asserted-by":"crossref","unstructured":"Davis MM, Andreae M, Freed GL. Physicians\u2019 early challenges related to the pneumococcal conjugate vaccine. Ambul Pediatr.\u20082001;1:302\u2013305","DOI":"10.1367\/1539-4409(2001)001<0302:PECRTT>2.0.CO;2"},{"key":"2021120823103059400_R21","doi-asserted-by":"crossref","unstructured":"Davis MM, Ndiaye SM, Freed GL, Kim CS, Clark SJ. Influence of insurance status and vaccine cost on physicians\u2019 administration of pneumococcal conjugate vaccine. Pediatrics.\u20082003;112:521\u2013526","DOI":"10.1542\/peds.112.3.521"},{"key":"2021120823103059400_R22","doi-asserted-by":"crossref","unstructured":"Schaffer SJ, Szilagyi PG, Shone LP, et al. Physician perspectives regarding pneumococcal conjugate vaccine. Pediatrics. 2002;110(6). Available at: www.pediatrics.org\/cgi\/content\/full\/110\/6\/e68","DOI":"10.1542\/peds.110.6.e68"},{"key":"2021120823103059400_R23","doi-asserted-by":"crossref","unstructured":"Zimet GD. Understanding and overcoming barriers to human papillomavirus vaccine acceptance. Curr Opin Obstet Gynecol.\u20082006;18(suppl 1):s23\u2013s28","DOI":"10.1097\/01.gco.0000216317.10690.8f"},{"key":"2021120823103059400_R24","doi-asserted-by":"crossref","unstructured":"Dell DL, Chen H, Ahmad F, Stewart DE. Knowledge about human papillomavirus among adolescents. Obstet Gynecol.\u20082000;96:653\u2013656","DOI":"10.1016\/S0029-7844(00)01009-7"},{"key":"2021120823103059400_R25","doi-asserted-by":"crossref","unstructured":"Holcomb B, Bailey JM, Crawford K, Ruffin MT. Adults\u2019 knowledge and behaviors related to human papillomavirus infection. J Am Board Fam Pract.\u20082004;17:26\u201331","DOI":"10.3122\/jabfm.17.1.26"},{"key":"2021120823103059400_R26","unstructured":"Centers for Disease Control and Prevention. Recommended childhood and adolescent immunization schedule\u2014United States, 2006. MMWR Morb Mortal Wkly Rep.\u20082005;54:Q1\u2013Q4"},{"key":"2021120823103059400_R27","doi-asserted-by":"crossref","unstructured":"Ziv A, Boulet JR, Slap GB. Utilization of physician offices by adolescents in the United States. Pediatrics.\u20081999;104:35\u201342","DOI":"10.1542\/peds.104.1.35"},{"key":"2021120823103059400_R28","doi-asserted-by":"crossref","unstructured":"Zimet GD, Mays RM, Winston Y, Kee R, Dickes J, Su L. Acceptability of human papillomavirus immunization. J Womens Health Gend Based Med.\u20082000;9:47\u201350","DOI":"10.1089\/152460900318957"},{"key":"2021120823103059400_R29","doi-asserted-by":"crossref","unstructured":"Daley MF, Crane LA, Chandramouli V, et al. Influenza among healthy young children: changes in parental attitudes and predictors of immunization during the 2003 to 2004 influenza season. Pediatrics. 2006;117(2). Available at: www.pediatrics.org\/cgi\/content\/full\/117\/2\/e268","DOI":"10.1542\/peds.2005-1752"},{"key":"2021120823103059400_R30","unstructured":"American Academy of Pediatrics. AAP Periodic Survey (PS-51). Available at: www.aap.org\/research\/periodicsurvey\/psof.htm. Accessed February 6, 2006"},{"key":"2021120823103059400_R31","unstructured":"Schuman H, Presser S. Measuring a middle position. In: Questions and Answers in Attitude Surveys. Experiments on Question Form, Wording, and Context. Thousand Oaks, CA. Sage Publications; 1996:161\u2013178"},{"key":"2021120823103059400_R32","doi-asserted-by":"crossref","unstructured":"McMahon SR, Iwamoto M, Massoudi MS, et al. Comparison of e-mail, fax, and postal surveys of pediatricians. Pediatrics. 2003;111(4). Available at: www.pediatrics.org\/cgi\/content\/full\/111\/4\/e299","DOI":"10.1542\/peds.111.4.e299"},{"key":"2021120823103059400_R33","doi-asserted-by":"crossref","unstructured":"Kahn JA, Zimet GD, Bernstein DI, et al. Pediatricians\u2019 intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health.\u20082005;37:502\u2013510","DOI":"10.1016\/j.jadohealth.2005.07.014"},{"key":"2021120823103059400_R34","doi-asserted-by":"crossref","unstructured":"Riedesel JM, Rosenthal SL, Zimet GD, et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol.\u20082005;18:391\u2013398","DOI":"10.1016\/j.jpag.2005.09.004"},{"key":"2021120823103059400_R35","doi-asserted-by":"crossref","unstructured":"Lazcano-Ponce E, Rivera L, Arillo-Santillan E, Salmeron J, Hernandez-Avila M, Munoz N. Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res.\u20082001;32:243\u2013247","DOI":"10.1016\/S0188-4409(01)00277-6"},{"key":"2021120823103059400_R36","doi-asserted-by":"crossref","unstructured":"Olshen E, Woods ER, Austin SB, Luskin M, Bauchner H. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health.\u20082005;37:248\u2013251","DOI":"10.1016\/j.jadohealth.2005.05.016"},{"key":"2021120823103059400_R37","doi-asserted-by":"crossref","unstructured":"Zimet GD, Mays RM, Sturm LA, Ravert AA, Perkins SM, Juliar BE. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med.\u20082005;159:132\u2013137","DOI":"10.1001\/archpedi.159.2.132"},{"key":"2021120823103059400_R38","doi-asserted-by":"crossref","unstructured":"Brabin L, Roberts SA, Farzaneh F, Kitchener HC. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine.\u20082006;24:3087\u20133094","DOI":"10.1016\/j.vaccine.2006.01.048"},{"key":"2021120823103059400_R39","doi-asserted-by":"crossref","unstructured":"Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics.\u20082006;117:1486\u20131493","DOI":"10.1542\/peds.2005-1381"},{"key":"2021120823103059400_R40","doi-asserted-by":"crossref","unstructured":"Mays RM, Sturm LA, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med.\u20082004;58:1405\u20131413","DOI":"10.1016\/S0277-9536(03)00335-6"},{"key":"2021120823103059400_R41","doi-asserted-by":"crossref","unstructured":"Szilagyi PG, Schaffer S, Barth R, et al. Effect of telephone reminder\/recall on adolescent immunization and preventive visits: results from a randomized clinical trial. Arch Pediatr Adolesc Med.\u20082006;160:157\u2013163","DOI":"10.1001\/archpedi.160.2.157"},{"key":"2021120823103059400_R42","doi-asserted-by":"crossref","unstructured":"Szilagyi PG, Bordley C, Vann JC, et al. Effect of patient reminder\/recall interventions on immunization rates: a review. JAMA.\u20082000;284:1820\u20131827","DOI":"10.1001\/jama.284.14.1820"},{"key":"2021120823103059400_R43","doi-asserted-by":"crossref","unstructured":"Zimet GD, Perkins SM, Sturm LA, Bair RM, Juliar BE, Mays RM. Predictors of STI vaccine acceptability among parents and their adolescent children. J Adolesc Health.\u20082005;37:179\u2013186","DOI":"10.1016\/j.jadohealth.2005.06.004"},{"key":"2021120823103059400_R44","unstructured":"Silverman E. Cancer vaccine will be a hard sell. Newark Star- Ledger. April 3, 2005:1"},{"key":"2021120823103059400_R45","doi-asserted-by":"crossref","unstructured":"Abma JC, Martinez GM, Mosher WD, Dawson BS. Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2002. Vital Health Stat.\u20082004;23:1\u201348","DOI":"10.1037\/e609162007-001"},{"key":"2021120823103059400_R46","doi-asserted-by":"crossref","unstructured":"Kirby D. The impact of schools and school programs upon adolescent sexual behavior. J Sex Res.\u20082002;39:27\u201333","DOI":"10.1080\/00224490209552116"},{"key":"2021120823103059400_R47","doi-asserted-by":"crossref","unstructured":"Raine TR, Harper CC, Rocca CH, et al. Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial. JAMA.\u20082005;293:54\u201362","DOI":"10.1001\/jama.293.1.54"},{"key":"2021120823103059400_R48","doi-asserted-by":"crossref","unstructured":"Stanton B, Li X, Pack R, Cottrell L, Harris C, Burns JM. Longitudinal influence of perceptions of peer and parental factors on African American adolescent risk involvement. J Urban Health.\u20082002;79:536\u2013548","DOI":"10.1093\/jurban\/79.4.536"},{"key":"2021120823103059400_R49","doi-asserted-by":"crossref","unstructured":"Whitaker DJ, Miller KS, May DC, Levin ML. Teenage partners\u2019 communication about sexual risk and condom use: the importance of parent-teenager discussions. Fam Plann Perspect.\u20081999;31:117\u2013121","DOI":"10.2307\/2991693"},{"key":"2021120823103059400_R50","doi-asserted-by":"crossref","unstructured":"Cohen DA, Farley TA, Taylor SN, Martin DH, Schuster MA. When and where do youths have sex? The potential role of adult supervision. Pediatrics. 2002;110(6). Available at: www.pediatrics.org\/cgi\/content\/full\/110\/6\/e66","DOI":"10.1542\/peds.110.6.e66"},{"key":"2021120823103059400_R51","doi-asserted-by":"crossref","unstructured":"Lonczak HS, Abbott RD, Hawkins JD, Kosterman R, Catalano RF. Effects of the Seattle social development project on sexual behavior, pregnancy, birth, and sexually transmitted disease outcomes by age 21 years. Arch Pediatr Adolesc Med.\u20082002;156:438\u2013447","DOI":"10.1001\/archpedi.156.5.438"},{"key":"2021120823103059400_R52","doi-asserted-by":"crossref","unstructured":"Averett SL, Rees DI, Argys LM. The impact of government policies and neighborhood characteristics on teenage sexual activity and contraceptive use. Am J Public Health.\u20082002;92:1773\u20131778","DOI":"10.2105\/AJPH.92.11.1773"},{"key":"2021120823103059400_R53","doi-asserted-by":"crossref","unstructured":"Raley JC, Followwill KA, Zimet GD, Ault KA. Gynecologists\u2019 attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol.\u20082004;12:127\u2013133","DOI":"10.1080\/10647440400020661"},{"key":"2021120823103059400_R54","doi-asserted-by":"crossref","unstructured":"Mays RM, Zimet GD. Recommending STI vaccination to parents of adolescents: the attitudes of nurse practitioners. Sex Transm Dis.\u20082004;31:428\u2013432","DOI":"10.1097\/01.OLQ.0000130536.71812.E5"},{"key":"2021120823103059400_R55","doi-asserted-by":"crossref","unstructured":"Garnett GP. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. J Infect Dis.\u20082005;191(suppl 1):S97\u2013S106","DOI":"10.1086\/425271"},{"key":"2021120823103059400_R56","doi-asserted-by":"crossref","unstructured":"Hughes JP, Garnett GP, Koutsky L. The theoretical population-level impact of a prophylactic human papilloma virus vaccine. Epidemiology.\u20082002;13:631\u2013639","DOI":"10.1097\/00001648-200211000-00006"},{"key":"2021120823103059400_R57","doi-asserted-by":"crossref","unstructured":"Taira AV, Neukermans CP, Sanders GD. Evaluating human papillomavirus vaccination programs. Emerg Infect Dis.\u20082004;10:1915\u20131923","DOI":"10.3201\/eid1011.040222"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/6\/2280\/1117393\/zpe01206002280.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/6\/2280\/1117393\/zpe01206002280.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T03:20:24Z","timestamp":1639020024000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/6\/2280\/69687\/A-National-Survey-of-Pediatrician-Knowledge-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,1]]},"references-count":57,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2006,12,1]]},"published-print":{"date-parts":[[2006,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-1946","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,1]]}}}